Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

517 ARTÍCULOS , VIENDO DEL 151 AL 165

Alterations of Audiovisual Integration in Alzheimer's Disease

Liu Y, Wang Z, Wei T, Zhou S, Yin Y, Mi Y, Liu X, Tang Y.

Neurosci Bull. 2023 Dec;39(12):1859-1872. doi: 10.1007/s12264-023-01125-7. Epub 2023 Oct 9.

Case Study 6: The Diagnostic Challenge of a 75-Year-Old Man Who Had, Then Didn't Have, Then Did Have Alzheimer's Disease

Ramírez-Salazar SA, MacRae C, Feany MB, Miller M, Yang HS, Meadows ME, McGinnis SM, Silbersweig D, Gale SA, Daffner KR.

J Neuropsychiatry Clin Neurosci. 2023 Fall;35(4):325-332. doi: 10.1176/appi.neuropsych.20230097.

The electronic health record Risk of Alzheimer's and Dementia Assessment Rule (eRADAR) Brain Health Trial: Protocol for an embedded, pragmatic clinical trial of a low-cost dementia detection algorithm

Dublin S, Greenwood-Hickman MA, Karliner L, Hsu C, Coley RY, Colemon L, Carrasco A, King D, Grace A, Lee SJ, Walsh JME, Barrett T, Broussard J, Singh U, Idu A, Yaffe K, Boustani M, Barnes DE.

Contemp Clin Trials. 2023 Dec;135:107356. doi: 10.1016/j.cct.2023.107356. Epub 2023 Oct 17.

Lecanemab Clarity AD: Quality-of-Life Results from a Randomized, Double-Blind Phase 3 Trial in Early Alzheimer's Disease

Cohen S, van Dyck CH, Gee M, Doherty T, Kanekiyo M, Dhadda S, Li D, Hersch S, Irizarry M, Kramer LD.

J Prev Alzheimers Dis. 2023;10(4):771-777. doi: 10.14283/jpad.2023.123.

Baseline Findings of PreventE4: A Double-Blind Placebo Controlled Clinical Trial Testing High Dose DHA in APOE4 Carriers before the Onset of Dementia

Yassine HN, Arellanes IC, Mazmanian A, De La Cruz L, Martinez J, Contreras L, Kono N, Liu BS, Badie D, Bantugan MA, Grindon A, Urich T, D'Orazio L, Emmanuel BA, Chui HC, Mack WJ, Harrington MG, Braskie MN, Schneider LS.

J Prev Alzheimers Dis. 2023;10(4):810-820. doi: 10.14283/jpad.2023.77.

Patient with PSEN1 Glu318Gly and Other Possible Disease Risk Mutations, Diagnosed with Early Onset Alzheimer's Disease

Yang Y, Bagyinszky E, An SSA.

Int J Mol Sci. 2023 Oct 23;24(20):15461. doi: 10.3390/ijms242015461.

Exploring cerebral amyloid angiopathy: Insights into pathogenesis, diagnosis, and treatment

Cozza M, Amadori L, Boccardi V.

J Neurol Sci. 2023 Nov 15;454:120866. doi: 10.1016/j.jns.2023.120866. Epub 2023 Nov 2.

Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease

Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group.

N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430.

Early Hippocampal Atrophy Is an Important Signal for Clinicians but Not Necessarily a Harbinger of Alzheimer Disease

Nelson PT, Jicha GA.

Neurology. 2023 Dec 12;101(24):1087-1088. doi: 10.1212/WNL.0000000000208071. Epub 2023 Nov 8.

A scoping review of interpretability and explainability concerning artificial intelligence methods in medical imaging

Champendal M, Müller H, Prior JO, Dos Reis CS.

Eur J Radiol. 2023 Dec;169:111159. doi: 10.1016/j.ejrad.2023.111159. Epub 2023 Oct 21.

A Literature Review on the Burden of Alzheimer's Disease on Care Partners

Frederiksen KS, Lanctôt KL, Weidner W, Hahn-Pedersen JH, Mattke S.

J Alzheimers Dis. 2023;96(3):947-966. doi: 10.3233/JAD-230487.

Systems Medicine as a Strategy to Deal with Alzheimer's Disease

Zeng XX, Zeng JB.

J Alzheimers Dis. 2023;96(4):1411-1426. doi: 10.3233/JAD-230739.

Neuropsychological Assessment of Older Adults in Nepal for Population-Based Dementia Ascertainment: Needs, Challenges, and Opportunities

Briceño EM, Dhakal U, Sharma U, Adhikari N, Pradhan MS, Shrestha L, Jalan P, Rai J, Langa KM, Lee J, Ghimire D, Mendes de Leon CF.

J Alzheimers Dis. 2023;96(4):1339-1352. doi: 10.3233/JAD-230906.

Impairments in sleep and brain molecular clearance in people with cognitive deterioration and biological evidence of AD: a report of four cases

Buongiorno M, Granell E, Caruana G, Sansa G, Vives-Gilabert Y, Cullell N, Molina-Seguin J, Almeria M, Artero C, Sánchez-Benavides G, Ray NJ, Correa SAL, Krupinski J.

BMC Neurol. 2023 Nov 22;23(1):417. doi: 10.1186/s12883-023-03460-8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias